Condition

Solid Carcinoma of Stomach

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions3

Lead sponsors shown2

Clinical trials

2 shown

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast CancerNCT03775525 · 2019-03-01

UNKNOWN

A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid TumorsNCT03129139 · 2017-10-10

UNKNOWN

Common interventions

CapecitabineDRUG1GZ17-6.02DRUG1Minnelide™CapsulesDRUG1

Leading sponsors

Genzada Pharmaceuticals USA, Inc.1Minneamrita Therapeutics LLC1

Trial status mix

UNKNOWN2

Phase mix

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.